CBD may help reduces REM behavior disorder in people with Parkinson’s disease. REM behavior disorder is a condition that causes people to act out physically during dreaming and REM sleep. Typically, during REM, the body is largely paralyzed, a state known as REM atonia. This immobilization keeps sleepers from reacting physically to their dreams. In REM behavior disorder, this paralysis doesn’t occur, leaving people free to move—which can lead to disruptive sleep and to injuring themselves or their sleeping partners. Cannabis may also work to reduce pain and improve sleep quality in people with Parkinson’s disease.
INGREDIENTS: ALCOHOL DENAT., HAMAMELIS VIRGINIANA (WITCH HAZEL) WATER, WATER (AQUA), PROPYLENE GLYCOL, ALCOHOL, LIDOCAINE, POLYSORBATE 20, GLYCERIN, CANNABINOID EXTRACT, ARNICA MONTANA FLOWER EXTRACT, ALOE BARBADENSIS LEAF EXTRACT, EUCALYPTUS GLOBULUS LEAF OIL, MENTHA PIPERITA (PEPPERMINT) OIL, CAMPHOR, MENTHOL, TOCOPHERYL ACETATE, ALLANTOIN, SODIUM BENZOATE, POTASSIUM SORBATE.
Scientists have made a lot of progress in understanding how CBD produces its calming, pain-reducing, anti-inflammatory effects in the body—and there’s still more to learn. We know that CBD interacts with many different receptors, proteins, and other chemicals in the brain. These interactions create changes in the activity of neurotransmitters, hormones, and other cells throughout the brain and body. Through these interactions, CBD appears to be able to affect many of the body’s functions, from sleep-wake cycles and emotional regulation to inflammation, pain perception, and seizures.
With that being said, let’s discuss the wonderful thing we call CBD oil. CBD oil is made from the specific hemp strain that is bred for fiber, topicals, nutritional benefits, and more. It is made from high-CBD, low-THC hemp. CBD oil is extracted using the whole plant or aerial parts. Aerial parts of the plant are parts which are completely exposed to air. Since hemp contains only trace amounts of THC, CBD oil products are non-psychoactive.
Despite this, CBD is something nobody knows much about, and certainly nobody is monitoring it properly. CBD is widely marketed as a supplement, despite the Food and Drug Administration saying it does not qualify as such (this is because it is an active ingredient in drugs which are either approved or under investigation to be approved). CBD goes largely unregulated by the agency; on the FDA’s FAQ page, a vague answer maintains there are “many factors in deciding whether or not to initiate an enforcement action.” The Department of Agriculture handles research grants and pilot programs for hemp, but that’s where its involvement ends.